N. Basosila, C. Inkoto, Ormiel Maganga, Blaise M. Mbembo, Giresse N. Kasiama, Carlos N. Kabengele, C. Falanga, C. Masengo, P. Mpiana, K. Ngbolua
{"title":"Biogenic Synthesis, Spectroscopic Characterization and Bioactivity of Cymbopogon citratus Derived Silver Nanoparticles","authors":"N. Basosila, C. Inkoto, Ormiel Maganga, Blaise M. Mbembo, Giresse N. Kasiama, Carlos N. Kabengele, C. Falanga, C. Masengo, P. Mpiana, K. Ngbolua","doi":"10.53293/jasn.2023.7012.1226","DOIUrl":null,"url":null,"abstract":"The use of plant extracts as a bio-reducer for the synthesis of silver nanoparticles has attracted attention due to its rapid, ecological, non-toxic and economical protocol. The aim of this study was to investigate the possibility of synthesizing silver nanoparticles using Cymbopogon citratus leaf extract, and characterizing them by Ultraviolet-visible spectroscopy, X-ray Diffraction and X-ray Fluorescence in order to determine their size and composition, as well as to evaluate them in-vitro bioactivity on selected models. The results of this study show that silver nanoparticles were successfully synthesized, with a size of 29.49 nm. The silver nanoparticles showed bactericidal activity against all three types of bacteria ( E. coli ATCC 25922, S. aureus ATCC 25923, and P. aerugunosa ATCC 27853) at the minimum inhibitory concentration (MIC=31.25 μg/mL), larvicidal activity against Anopheles larvae and reasonable antioxidant properties. All these results demonstrate the biopharmaceutical potential of these new products. These nanoparticles, synthesized from plant extracts, could be a promising solution for the treatment of a number of diseases, including malaria, bacterial infections and diseases caused by oxidative stress.","PeriodicalId":15241,"journal":{"name":"Journal of Applied Sciences and Nanotechnology","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Sciences and Nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53293/jasn.2023.7012.1226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The use of plant extracts as a bio-reducer for the synthesis of silver nanoparticles has attracted attention due to its rapid, ecological, non-toxic and economical protocol. The aim of this study was to investigate the possibility of synthesizing silver nanoparticles using Cymbopogon citratus leaf extract, and characterizing them by Ultraviolet-visible spectroscopy, X-ray Diffraction and X-ray Fluorescence in order to determine their size and composition, as well as to evaluate them in-vitro bioactivity on selected models. The results of this study show that silver nanoparticles were successfully synthesized, with a size of 29.49 nm. The silver nanoparticles showed bactericidal activity against all three types of bacteria ( E. coli ATCC 25922, S. aureus ATCC 25923, and P. aerugunosa ATCC 27853) at the minimum inhibitory concentration (MIC=31.25 μg/mL), larvicidal activity against Anopheles larvae and reasonable antioxidant properties. All these results demonstrate the biopharmaceutical potential of these new products. These nanoparticles, synthesized from plant extracts, could be a promising solution for the treatment of a number of diseases, including malaria, bacterial infections and diseases caused by oxidative stress.